Anti-tumour effects of antibodies targeting the extracellular cysteine-rich region of the receptor tyrosine kinase EphB4.

about

Strategies of targeting the extracellular domain of RON tyrosine kinase receptor for cancer therapy and drug delivery.

P2860

Q38922319-598BE7DB-21BD-418F-B408-AA37904722CA

P2860

Anti-tumour effects of antibodies targeting the extracellular cysteine-rich region of the receptor tyrosine kinase EphB4.

Item

http://www.wikidata.org/entity/Q41828383

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Anti-tumour effects of antibod ...... eceptor tyrosine kinase EphB4.

@en

type

Item

label

Anti-tumour effects of antibod ...... eceptor tyrosine kinase EphB4.

@en

prefLabel

Anti-tumour effects of antibod ...... eceptor tyrosine kinase EphB4.

@en

P1476

Anti-tumour effects of antibod ...... receptor tyrosine kinase EphB4

@en

P2093

Adrian C Herington

http://www.w3.org/2001/XMLSchema#string

Evelyn L Douglas

http://www.w3.org/2001/XMLSchema#string

Inga Mertens-Walker

http://www.w3.org/2001/XMLSchema#string

Mohanan S N Maharaj

http://www.w3.org/2001/XMLSchema#string

Sally-Anne Stephenson

http://www.w3.org/2001/XMLSchema#string

P2860

Forward EphB4 signaling in endothelial cells controls cellular repulsion and segregation from ephrinB2 positive cells

EphB4 expression and biological significance in prostate cancer

Molecular distinction and angiogenic interaction between embryonic arteries and veins revealed by ephrin-B2 and its receptor Eph-B4

Receptor protein tyrosine kinase EphB4 is up-regulated in colon cancer

Investigation of the expression of the EphB4 receptor tyrosine kinase in prostate carcinoma.

Symmetrical mutant phenotypes of the receptor EphB4 and its specific transmembrane ligand ephrin-B2 in cardiovascular development

Coexpression of ephrin-Bs and their receptors in colon carcinoma

Cell-type specific and estrogen dependent expression of the receptor tyrosine kinase EphB4 and its ligand ephrin-B2 during mammary gland morphogenesis

Expression of the receptor protein tyrosine kinase myk-1/htk in normal and malignant mammary epithelium

The cytoplasmic domain of the ligand ephrinB2 is required for vascular morphogenesis but not cranial neural crest migration.

P304

7554-7569

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.3199

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Jessica Lisle

P577

2015-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

274400562

http://www.w3.org/2001/XMLSchema#string

P698

25831049

http://www.w3.org/2001/XMLSchema#string

P932

4480699

http://www.w3.org/2001/XMLSchema#string

Anti-tumour effects of antibodies targeting the extracellular cysteine-rich region of the receptor tyrosine kinase EphB4.

about

P2860

P2860

Anti-tumour effects of antibodies targeting the extracellular cysteine-rich region of the receptor tyrosine kinase EphB4.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P5875

P698

P932